患有炎症性风湿性疾病和并发症的患者的康复:未得到满足的需求
Yuliya Fedorchenko1, Khaiyom Mahmudov2, Zhumabek Abenov3,4
1Department of Pathophysiology, Ivano-Frankivsk National Medical University, Halytska Str. 2, Ivano-Frankivsk, 76018, Ukraine. juliakozubash@gmail.com.
Rheumatology international
|January 31, 2024
概括
类风湿性疾病中的并发症加剧了结果. 多学科康复,包括物理治疗和心脏康复,改善功能,减少疾病活动,降低这些患者的死亡风险.
科学领域:
- 类风湿病学 类风湿病学
- 康复医学 康复医学 康复医学
- 心脏病学 心脏病学
背景情况:
- 在类风湿性关节炎 (RA),全身性红斑狼 (SLE) 和牛皮性关节炎 (PsA) 等炎症性类风湿性疾病 (IRD) 中,并发症很普遍.
- 这些同时存在的疾病可能导致治疗反应不佳,加速残疾和死亡率增加.
- 常见的并发病包括心血管,瘤和传染病.
研究的目的:
- 突出多学科方法的必要性,在管理风湿患者的伴随性疾病.
- 强调康复在改善功能移动性和疾病结果方面的作用.
- 审查支持IRD心脏康复和物理治疗的证据.
主要方法:
- 文献综述和证据综合研究对伴随疾病的IRD的康复策略.
- 对调查体育炼和心脏康复影响的研究进行分析.
- 专注于多学科的护理模式和自我管理建议.
主要成果:
- 心脏康复可以安全地在IRD患者中实施,降低具有风险因素的患者的死亡率.
- 身体炼显然可以减少疾病的严重程度,改善临床过程,并降低住院率.
- 有重点物理治疗的康复计划增强功能能力,减少疾病活动,改善生活质量.
结论:
- 一种多学科的康复方法对于管理伴随病情的风湿性疾病至关重要.
- 有证据支持将心脏康复和物理治疗整合起来,以改善患者的治疗结果.
- 卫生专业人员必须提供基于证据的指导,以自我管理和预防并发症.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Restorative Care
2.0K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.0K
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137


